|
|
Product Name: Erlotinib
Generic Name: Erlotinib
Common Brands: Tarceva
Pharmaceutical Categories: Cancer
Where to buy Erlotinib online:
| Shop | Product | Forms | Strength | Conditions |
| MEDS FOR SALE | | Tarceva tablets 150 mg | 5% discount coupon: 5OFFPayment: Visa, Mastercard, AmEx, Bitcoin, Tether (USDT)Shipping: worldwideDelivery: unregistered mail, trackable courier |
| PHARM X SELLER | | Erlonat tablets 100 mgErlonat tablets 150 mg | 10% discount coupon: 918cc60b466a42baPayment: PayBis, Cryptocurrency, MG, WU, ZelleShipping: worldwideDelivery: registered airmail, FedEx, DHL |
Erlotinib (trade names include Tarceva, Erlocip, Erlonat, Zyceva) is an anti-cancer medication from protein kinase inhibitors pharmacological group. This medicine is used for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works as an epidermal growth factor receptor inhibitor (EGFR inhibitor).
Customers also buy these medications from the same pharmacological classes:
Afatinib (Gilotrif)
Alectinib (Alecensa)
Cabozantinib (Cabometyx, Cometriq)
Crizotinib (Xalkori)
Dabrafenib (Tafinlar)
Entrectinib (Rozlytrek)
Everolimus (Zortress, Certican)
Icotinib (Conmana)
Imatinib (Gleevec)
Lapatinib (Tykerb, Tyverb)
Lenvatinib (Lenvima, Lenvanix)
Midostaurin (Rydapt)
Neratinib (Nerlynx)
Nilotinib (Tasigna)
Palbociclib (Ibrance)
Quizartinib (Vanflyta)
Ribociclib (Kisqali)
Ridaforolimus (Deforolimus)
Sorafenib (Nexavar)
Sunitinib (Sutent)
Pharmaceutical and medical classifications:
Anti cancer drugs
Antineoplastic medicines
Cytostatic agents
Epidermal growth factor receptor tyrosine kinase (EGFR) inhibitors
NSCLC treatment medications
Oncological treatment
Pancreatic cancer therapy
The Anatomical Therapeutic Chemical (ATC) classification system (developed by the World Health Organization):
L - Antineoplastic and immunomodulating agents
L01 - Antineoplastic agents
L01X - Other antineoplastic agents
L01XE - Protein kinase inhibitors
L01XE03 - Erlotinib
Medical conditions for erlotinib in the International Statistical Classification of Diseases and Related Health Problems:
Malignant neoplasm of pancreas - C25
Malignant neoplasm of bronchus and lung - C34
Pregnancy category:
C - Australia (Risk cannot be ruled out)
N - United States (Not classified yet)
Forms of active pharmaceutical ingredients (APIs):
Erlotinib Base
Erlotinib Hydrochloride
Erlotinib Mesylate
Chemical, international, and other names of this drug:
Erlotinibe
Erlotinibi
Erlotinibum
Erlotynib
Most known trade names (brands and generics) worldwide:
Erlocip - Cipla
Erlonat - Natco Pharma
Erlotinib - Mylan
Tarceva - Roche, Astellas Pharma, Genentech, OSI Pharmaceuticals, Schwarz Pharma
Zyceva - Zydus pharmaceuticals
References and external sources:
Erlotinib main article on Wikipedia: https://en.wikipedia.org/wiki/Erlotinib
Erlotinib compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erlotinib
Erlotinib Hydrochloride compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erlotinib-hydrochloride
Erlotinib medicine on DrugBank: https://www.drugbank.ca/drugs/DB00530
Erlotinib Hydrochloride on DrugBank: https://www.drugbank.ca/salts/DBSALT000064
Erlotinib FAQ on MedlinePlus (revised 03/15/2017): https://medlineplus.gov/druginfo/meds/a605008.html
Tarceva (Erlotinib Hydrochloride) tablets drug label on DailyMed (revised December 12, 2018): https://dailymed.nlm.nih.gov/dailymed/lookup...
Shilpa Medicare Erlotinib Hydrochloride film-coated tablets drug label on DailyMed (revised October 25, 2019): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Tarceva (Erlotinib Hydrochloride) oral tablets official prescribing and patient counseling information from the U.S. FDA (revised 10/2016): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Tarceva (Erlotinib Hydrochloride) tablets for oral use prescribing and patient information from Genentech pharmaceutical company (revised 10/2016): https://www.gene.com/download/pdf/tarceva_prescribing.pdf
Tarceva (Erlotinib) tablets official website powered by Roche: https://www.tarceva.global/
Tarceva (Erlotinib HCl) 25 mg, 100 mg, 150 mg film-coated tablets package information leaflet on Medicines.org.uk (revised January 2022): https://www.medicines.org.uk/emc/files/pil.8845.pdf
Erlocip (Erlotinib, Tarceva generic) 100 mg and 150 mg tablets prescribing information from Cipla pharmaceutical company (revised 16/06/2021): https://www.ciplamed.com/content/erlocip-tablets
Revised: May 2022
|
Disclaimer: Please note, this website is not an online pharmacy, drugstore and related online pharma shop. It does not sell, supply or advertise any prescription and OTC drugs, medications, other goods and services. All reviews, links, lists, databases, texts, videos, images, and other content on the website are provided free and only for informational and educational purposes. Medical content on this website, including drug names, indications, contraindication, side effects, categories, classifications, forms, doses, prices, other health and pharmaceutical information are taken only from trusted and authoritative professional sources (see "References"), reviewed and prepared by our licensed experts, content inspectors and editors.
You should always consult your doctor or other healthcare professional before using any medication. This website, our staff and support do not provide own medical instructions and advices.
All brands and trade names appearing on the website are registered trademarks and intellectual property of their respective companies.
Remember that buying drugs and medicines online is a responsibility only of customers, sellers and suppliers regarding existing legislation in their jurisdictions.
|
|